Cardiac health in patients with hepatitis B virus-related cirrhosis.


Journal

Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R

Informations de publication

Date de publication:
Mar 2019
Historique:
entrez: 29 3 2019
pubmed: 29 3 2019
medline: 23 4 2019
Statut: ppublish

Résumé

Not only alcoholic cirrhosis related to cardiac dysfunction, cirrhosis caused by nonalcoholic etiology including hepatitis B virus (HBV) infection also related to impaired cardiac health. The aims of present study were to perform a noninvasive evaluation of cardiac function and to evaluate exercise performance in HBV related cirrhotic patients without typical symptoms of cardiac disease.Seventy-nine HBV related cirrhotic patients and 103 matched subjects without a previous history of cardiac involvement were recruited. Clinical examination and cardiac health evaluation were performed. The incidence, risk factors of cardiac dysfunction and exercise tolerance were investigated.A correlation between QTc interval and model for end-stage liver disease score (R = 0.239, P = .018) was detected, however, the connection between QTc prolongation and the severity of liver disease was uncertain. Patients with HBV related cirrhosis had a tendency toward left ventricular wall thickening (P = .007). Forty-one patients (51.90%) were in accordance with the definition of cirrhotic cardiomyopathy, and a significant increase in the incidence of cardiac diastolic dysfunction (CDD) could be found with increasing Child-Pugh grade (P = .004). HBV related cirrhotic patients with CDD had a higher level of pro-brain natriuretic peptide (P = .025), international normalized ratio (P = .010) Child-Pugh score (P = .020), and a higher proportion of ascites (P < .001). The higher Child-Pugh score (odds ratio = 1.662, P = .010) was an independent diagnostic predictor of CDD. The cardiac depression and exercise tolerance also got worse with increasing Child-Pugh score (P < .001).Impaired cardiac health was common in HBV related cirrhotic patients. Cardiogenic factors must be carefully considered in the integral therapy of cirrhosis. Hepatology physicians should lay emphasis on exercise training in daily life.

Identifiants

pubmed: 30921198
doi: 10.1097/MD.0000000000014961
pii: 00005792-201903290-00024
pmc: PMC6456085
doi:

Substances chimiques

Lipids 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e14961

Références

Gut. 2003 Oct;52(10):1511-7
pubmed: 12970147
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
Int J Cardiol. 2012 Nov 29;161(3):130-6
pubmed: 21839528
Nutrition. 2015 Jul-Aug;31(7-8):971-4
pubmed: 26059370
Adv Exp Med Biol. 2017;1000:31-49
pubmed: 29098614
J Clin Gastroenterol. 2004 Nov-Dec;38(10 Suppl 3):S158-68
pubmed: 15602165
Clin Transplant. 2012 Jan-Feb;26(1):111-6
pubmed: 21447142
ScientificWorldJournal. 2012;2012:615057
pubmed: 22888308
Nutrition. 2018 Mar;47:21-26
pubmed: 29429530
Phys Ther. 2016 Sep;96(9):1456-67
pubmed: 27055540
J Hepatol. 2005 Jan;42(1):68-74
pubmed: 15629509
Gut. 2008 Feb;57(2):268-78
pubmed: 18192456
J Clin Invest. 1953 Oct;32(10):1025-33
pubmed: 13096569
Hepatol Int. 2012 Jun;6(3):531-61
pubmed: 26201469
Int J Cardiol. 2013 Aug 20;167(4):1101-8
pubmed: 23041091
J Gastroenterol. 2016 Jul;51(7):629-50
pubmed: 27246107
J Interferon Cytokine Res. 2017 Mar;37(3):97-102
pubmed: 28068153
Ann Hepatol. 2011 Jul-Sep;10(3):321-6
pubmed: 21677334
J Chin Med Assoc. 2012 Dec;75(12):619-23
pubmed: 23245476
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Zhonghua Yi Xue Za Zhi. 2007 Oct 16;87(38):2717-8
pubmed: 18167253
Liver Transpl. 2017 Jun;23(6):826-835
pubmed: 28407402
Clin Sci (Lond). 2009 May 14;116(12):851-9
pubmed: 19076059
JAMA. 2012 Aug 1;308(5):465-74
pubmed: 22851113
Hepatology. 2003 Sep;38(3):589-98
pubmed: 12939585
Am J Cardiol. 2008 Oct 15;102(8):1097-102
pubmed: 18929716
Vaccine. 2012 Mar 9;30(12):2212-9
pubmed: 22273662
Pathol Res Pract. 2015 Feb;211(2):145-9
pubmed: 25468291
J Psychosom Res. 2008 Aug;65(2):123-9
pubmed: 18655856
Hepatology. 1998 Jan;27(1):28-34
pubmed: 9425913
Int Cardiovasc Res J. 2014 Apr;8(2):39-43
pubmed: 24936479
Eur J Heart Fail. 2011 Feb;13(2):115-26
pubmed: 21148593
Radiol Med. 2014 Dec;119(12):903-909
pubmed: 24846081

Auteurs

Wei Yuan (W)

Department of Liver Intensive Care Unit.

Hong-Zhou Lu (HZ)

Department of Infectious Disease, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Xue Mei (X)

Department of Liver Intensive Care Unit.

Yu-Yi Zhang (YY)

Department of Liver Intensive Care Unit.

Zheng-Guo Zhang (ZG)

Department of Liver Intensive Care Unit.

Ying Zou (Y)

Department of Liver Intensive Care Unit.

Jie-Fei Wang (JF)

Department of Liver Intensive Care Unit.

Zhi-Ping Qian (ZP)

Department of Liver Intensive Care Unit.

Hong-Ying Guo (HY)

Department of Liver Intensive Care Unit.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH